GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns

(MedPage Today) -- A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded.
Following a review of all available data, the...